department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

the cabinet

Drugs

8,127 products tracked · 371 matching

★ save view ↓export CSV

phase

all Marketed Phase 3 Phase 2 Phase 1 Preclinical

sort

catalysts recent name

therapeutic area

all Oncology1831 Infectious Disease718 Cardiology425 Pulmonology396 Immunology371 Ophthalmology368 Dermatology300 Women's Health131

Phase 2
tulisokibart
tulisokibart
Systemic Sclerosis (Scleroderma)$MRK Merck & Co., Inc.1 cat
Phase 3
(atisnolerbart + bremzalerbart + umesolerbart)
(atisnolerbart + bremzalerbart + umesolerbart)
Birch Pollen Allergy$REGN REGENERON PHARMACEUTICALS, INC.
Marketed
(betamethasone acetate + betamethasone sodium phosphate)
Celestone Soluspan ((betamethasone acetate + betamethasone sodium phosphate))
Cerebral Edema$OGN Organon & Co.

page 3 of 13

Phase 2

(cilnidipine + tadalafil)

(cilnidipine [INN] + tadalafil)

Systemic Sclerosis (Scleroderma) AISA Pharma Inc

Marketed

(dextromethorphan + promethazine)

Promethazine DM ((dextromethorphan [INN] + promethazine [INN]))

Nasopharyngitis (Common Cold) PAI Holding Co LLC

Phase 3

(efgartigimod alfa + hyaluronidase (human recombinant))

Vyvgart Hytrulo ((efgartigimod alfa + hyaluronidase (human recombinant)-qvfc))

Idiopathic Inflammatory Myopathy (IIM)$ARGX ARGENX SE

Marketed

(fluocinolone acetonide + neomycin)

Neo-Synalar ((fluocinolone acetonide + neomycin [INN]))

Psoriasis Medicis Pharmaceutical Corp

Marketed

(halobetasol propionate + tazarotene)

Duobrii ((halobetasol propionate + tazarotene))

Plaque Psoriasis (Psoriasis Vulgaris) Ortho Dermatologics Inc

Marketed

(hyaluronidase (recombinant, human) + immune globulin (human))

HyQvia (hyaluronidase (recombinant, human) + immune globulin (human))

Primary Immune Deficiency (PID) Baxalta Inc

Marketed

(hydrocortisone acetate + pramocaine)

Proctofoam HC ((hydrocortisone acetate + pramocaine [INN]))

Anorectal Inflammation Mylan Specialty LP

Preclinical

Sicca Syndrome (Sjogren) 6S Pharma LLC

Phase 1

Psoriasis$ABBV AbbVie Inc.

Preclinical

Autoimmune Disorders AbelZeta Inc

Phase 1

Systemic Sclerosis (Scleroderma)$MRK Merck & Co., Inc.

Phase 2

Immunoglobulin G4-Related Disease (IgG4-RD) Acepodia Inc

Phase 1

Myasthenia Gravis Alpha Cancer Technologies Inc

Preclinical

AChE Inhibitors

Acne Vulgaris Attillaps Holdings Inc

Phase 1

Lupus Nephritis$ALLO Allogene Therapeutics, Inc.

Preclinical

Idiopathic Pulmonary Fibrosis APIE Therapeutics Inc

Phase 1

Chemotherapy Induced Peripheral Neuropathy$ARTL ARTELO BIOSCIENCES, INC.

Phase 1

Plaque Psoriasis (Psoriasis Vulgaris) Ascletis Pharma Inc

Phase 1

Graft Versus Host Disease (GVHD) ASC Therapeutics Inc

Phase 1

Systemic Lupus Erythematosus$AUPH Aurinia Pharmaceuticals Inc.

Phase 2

Refractory Multiple Myeloma Gracell Biotechnologies Inc

pre_registration

Anti-inflammatory

Post-Operative Pain AimMax Therapeutics Inc

Phase 2

Autologous Adipose-derived Stem Cells

Osteoarthritis CellTex Therapeutics Corp

Phase 1

Lupus Nephritis$BIIB BIOGEN INC.

Phase 1

Diffuse Cutaneous Systemic Sclerosis Bristol-Myers Squibb Co

Preclinical

Inflammation PharmaTher Holdings Ltd

Preclinical

Systemic Sclerosis (Scleroderma) RadBio